Pharma Co. Seeks Justice Review Over Updating Statements
Executives at now-bankrupt biotechnology company Orexigen Therapeutics Inc. have asked the U.S. Supreme Court to review the Ninth Circuit's finding that the company should have alerted the public when it learned...To view the full article, register now.
Already a subscriber? Click here to view full article